Adequacy of haemodialysis and associated factors among patients with end-stage kidney disease in Tanzania

被引:2
|
作者
Bakari, Abilah I. [1 ]
Yahaya, James J. [2 ]
Matobogolo, Boaz M. [1 ]
Abraham, Zephania S. [3 ]
Mpondo, Bonaventura [1 ]
机构
[1] Univ Dodoma, Sch Med & Dent, Dept Internal Med, Dodoma, Tanzania
[2] Soroti Univ, Sch Hlth Sci, Dept Pathol, POB 211, Soroti, Uganda
[3] Univ Dodoma, Sch Med & Dent, Dept Surg, Dodoma, Tanzania
来源
关键词
Adequacy; Chronic kidney disease; Clinical outcome; Factors associated; Haemodialysis; TWICE-WEEKLY HEMODIALYSIS; DIALYSIS INITIATION; MORTALITY; PREVALENCE; CARE;
D O I
10.1016/j.jtumed.2023.12.008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Adequate haemodialysis helps maintain normal renal function by removing toxins and other waste products in patients with end-stage kidney disease. This study was aimed at determining the prevalence and predictors of adequacy of haemodialysis and outcomes in patients with end-stage kidney disease. Methods: This longitudinal analytical hospital-based study was conducted at two dialysis centres in Dodoma city, Tanzania, between February and July of 2020. Adequacy of haemodialysis was measured with single-pool (sp) Kt/V and urea reduction rate (URR) formulae. Binary logistic regression and multivariable analysis were used to assess the independent predictors of adequacy of haemodialysis. Results: The analysis included 100 patients with a mean age of 50.6 +/- 15.0 years. The prevalence of adequacy of haemodialysis according to URR and sp-Kt/V was 72 % and 75 %, respectively. Having <12 months since dialysis initiation (AOR = 7.3, 95 % CI = 0.11-0.90, p = 0.032), fewer than three dialysis sessions per week (AOR = 6.9, 95 % CI = 1.52-31.49, p = 0.013) and severe anaemia (AOR = 2.2, 95 % CI = 0.26-0.93, p = 0.033) were predictors of inadequate haemodialysis, according to the URR formula. Having fewer than three dialysis sessions per week was significantly associated with inadequate haemodialysis (AOR = 5.6, 95 % CI = 1.47-19.66, p = 0.011), according to the sp-Kt/V formula. The mortality rate was 11.2 %, and cardiovascular disease and uremic syndrome were responsible for most deaths. Conclusion: This study indicated a high percentage of adequacy of haemodialysis among patients with endstage kidney disease. Having fewer than three dialysis sessions per week, late initiation of dialysis after diagnosis of end-stage kidney disease and severe anaemia were predictors of inadequate haemodialysis among patients.
引用
收藏
页码:287 / 295
页数:9
相关论文
共 50 条
  • [21] Prevalence of glycemic variability and factors associated with the glycemic arrays among end-stage kidney disease patients on chronic hemodialysis
    Yusof Khan, Abdul Hanif Khan
    Zakaria, Nor Fadhlina
    Zainal Abidin, Muhammad Adil
    Kamaruddin, Nor Azmi
    MEDICINE, 2021, 100 (30) : E26729
  • [22] THE EFFECT OF HEMODIALYSIS ADEQUACY ON VENTRICULAR REPOLARIZATION IN END-STAGE KIDNEY DISEASE
    Kalayci, Belma
    Onan, Engin
    Paydas, Saime
    Kaya, Bulent
    Adam, Fatma Ulku
    Besli, Serkan
    Kalayci, Suleyman
    Kokturk, Furuzan
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
  • [23] The role of psychological factors in fatigue among end-stage kidney disease patients: a critical review
    Picariello, Federica
    Moss-Morris, Rona
    Macdougall, Iain C.
    Chilcot, Joseph
    CLINICAL KIDNEY JOURNAL, 2017, 10 (01) : 79 - 88
  • [24] Prevalence of risk factors for foot ulceration in patients with end-stage renal disease on haemodialysis
    Kaminski, M.
    Frescos, N.
    Tucker, S.
    INTERNAL MEDICINE JOURNAL, 2012, 42 (06) : E120 - E128
  • [25] The prevalence and risk of mortality associated with intradialytic hypertension among patients with end-stage kidney disease on haemodialysis: A systematic review and meta-analysis
    Adejumo, Oluseyi Ademola
    Edeki, Imuetinyan Rahsida
    Oyedepo, Dapo Sunday
    Yisau, Olawale Elijah
    Ige, Olanrewaju Olumide
    Ekrikpo, Inyeneabasi Udeme
    Moussa, Ayman Sabri
    Palencia, Hansel
    Noubiap, Jean Jacques
    Ekrikpo, Udeme Ekpenyong
    PLOS ONE, 2024, 19 (06):
  • [26] Quality of life of patients on haemodialysis for end-stage renal disease
    Cleary, J
    Drennan, J
    JOURNAL OF ADVANCED NURSING, 2005, 51 (06) : 577 - 586
  • [27] Removal of clodronate by haemodialysis in end-stage renal disease patients
    Beigel, AE
    Rienhoff, E
    Olbricht, CJ
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1995, 10 (12) : 2266 - 2268
  • [28] The pharmacokinetics of etanercept in patients with end-stage renal disease on haemodialysis
    Don, BR
    Spin, G
    Nestorov, I
    Hutmacher, M
    Rose, A
    Kaysen, GA
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2005, 57 (11) : 1407 - 1413
  • [29] INFLAMMATORY MARKERS IN END-STAGE RENAL DISEASE PATIENTS ON HAEMODIALYSIS
    Abdel-Messeih, Phebe Lotfy
    Alkady, Manal Mohamed
    Nosseir, Neveen Mostafa
    Tawfik, Mohamed Said
    JOURNAL OF MEDICAL BIOCHEMISTRY, 2020, 39 (04) : 481 - 487
  • [30] What to do with foundation therapies for heart failure for patients with end-stage kidney disease on haemodialysis
    Adenwalla, Sherna F.
    Hull, Katherine L.
    Graham-Brown, Matthew P. M.
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2024, 85 (04)